Stem Cell Transplant Effective as First Line in Aggressive MS

October 17, 2018

(Medscape) – More very encouraging data on the use of autologous stem cell transplant in multiple sclerosis (MS) have been presented. There was no evidence of disease activity post transplant in patients who previously had extremely aggressive disease. The case series of 20 patients was reported at the 34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 2018 here by Joyutpal Das, MBBS, Royal Hallamshire Hospital Sheffield, United Kingdom.